Pharmaron Beijing Co LtdHere is the public summary page for Pharmaron Beijing Co Ltd. Please login to see the complete information for Pharmaron Beijing Co Ltd including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how Pharmaron Beijing Co Ltd stacks up relative to its peers. |
Darwin Score | +28 |
Ticker | 300759 |
Latest Price | 30.84 CNY as of close on 13-Aug-2025 |
3 Month price range | 22.16 to 32.84 CNY |
Market Capitalisation | 48.26Bn CNY |
Country | China |
Region | Europe |
Economic Sector | Health Care |
Business Sector | Pharmaceuticals, Biotechnology & Life Sciences |
Industry | Biotechnology |
Sub-Industry | Biotechnology |
Description | Pharmaron Beijing Co., Ltd., together with its subsidiaries, provides drug research and development, and production services to the life sciences industry in North America, Europe, Japan, Mainland China, and internationally. The company offers laboratory chemistry services, including medicinal and synthetic chemistry, chemistry for new modalities, radiolabelling and radiosynthesis, analytical and purification chemistry, DNA-encoded libraries, cheminformatics, and computer-aided drug design; bioscience services, such as structural biology, in vitro biology, DMPK, in vivo pharmacology, and compound management services; chemistry, manufacturing, and controls services. It also provides clinical development services, including integrated radio labelled science, clinical development, and clinical trial recruitment services; safety assessment, integrated drug discovery, and bioanalysis services; and biologics and cell and gene therapy services, comprising biologics laboratory, biologics CDMO, cell and gene therapy laboratory, and gene therapy CDMO services. Pharmaron Beijing Co., Ltd. was incorporated in 2004 and is headquartered in Beijing, the People's Republic of China. See More ... |
Company URL | https://www.pharmaron.com |
See Darwins Full Analysis for Pharmaron Beijing Co Ltd |
Tell Me About
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Pharmaron Beijing Co Ltd. Further information and full detail is available when you login.
TMA Part | Focus of Analysis | TMA Score |
---|---|---|
Price | Analysis of performance, trend, RSI, OBV and moving averages | +25 |
Sentiment | News and Candle Patterns. | 0 |
Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | +4 |
Flow | Institutional, Fund and Insider buying and selling. | 0 |
Models | Forecast models. | -1 |
Peer Comparison
There are 3 peers of Pharmaron Beijing Co Ltd.
Asset Name | Industry Group | Asset Score |
---|---|---|
Chongqing Zhifei Bio Products (300122) | Biotechnology | -9 |
Hualan Biological EngineeringInc (002007) | Biotechnology | +15 |
Shanghai RAAS Blood Products Co Ltd Class A (002252) | Biotechnology | -3 |